Skip to content

Health agencies should challenge the idea that most gay men use drugs

Sofosbuvir/ledipasvir is effective for people with HIV/HCV co-infection in real-world clinical practice

Grazoprevir triple regimen demonstrates high cure rates, even for hard-to-treat people

Eric Lawitz, presenting at AASLD 2016. Photo by Liz Highleyman, hivandhepatitis.com

World AIDS Day

World AIDS Day

People with HIV/HCV co-infection see good cure rates in real-world practice in Madrid

Juan Gonzalez Garcia, presenting at AASLD 2016. Photo by Liz Highleyman, hivandhepatitis.com

Chemsex and slamming “suffused with romantic, emotional and communal attachments”

8-week triple DAA combo cures most people with genotype 1-6 hepatitis C

Graham Foster, presenting at AASLD 2016. Photo by Liz Highleyman, hivandhepatitis.com

Birth cohort screening and linkage to care for HCV treatment still weak in United States

AbbVie pangenotypic combination cures 98% or above across genotypes

Stefan Zeuzem, presenting at AASLD 2016. Photo by Liz Highleyman, hivandhepatitis.com